Jingli Lu

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 11

Top Topics

Community Dwelling

Randomized Controlled Trial

Klebsiella Pneumoniae

Top Venues

Microbiology spectrum

Diabetes/metabolism research and reviews

Cancer medicine

Clinical & translational immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Haiyang Meng, Yongmei Zhao, Qi An, Baoling Zhu, Zhe Cao, Jingli Lu
Use of Ceftazidime-Avibactam for Suspected or Confirmed Carbapenem-Resistant Organisms in Children: A Retrospective Study. Infection and drug resistance 16 (2023)
Xiaofen Zhang, Li Gao, Haiyang Meng, Ailing Zhang, Yan Liang, Jingli Lu
Obesity alters immunopathology in cancers and inflammatory diseases. Obesity reviews : an official journal of the International Association for the Study of Obesity (2023)
Jingli Lu, Ailing Zhang, Lu Han, Zhen Guo, Wenjing Cui, Yuhua Jiang, Haiyang Meng
Clinical Outcomes and Risk Factors for Death following Carbapenem-Resistant Klebsiella pneumoniae Infection in Solid Organ Transplant Recipients. Microbiology spectrum (2022)
Jingli Lu, Ailing Zhang, Lu Han, Zhen Guo, Wenjing Cui, Yuhua Jiang, Haiyang Meng
Clinical Outcomes and Risk Factors for Death following Carbapenem-Resistant Klebsiella pneumoniae Infection in Solid Organ Transplant Recipients. Microbiology spectrum 11 (1) (2022)
Jingli Lu, Ailing Zhang, Lu Han, Zhen Guo, Wenjing Cui, Yuhua Jiang, Haiyang Meng
Clinical Outcomes and Risk Factors for Death following Carbapenem-Resistant Klebsiella pneumoniae Infection in Solid Organ Transplant Recipients. Microbiology spectrum 11 (1) (2022)
Jingli Lu, Ailing Zhang, Lu Han, Zhen Guo, Wenjing Cui, Yuhua Jiang, Haiyang Meng
Clinical Outcomes and Risk Factors for Death following Carbapenem-Resistant Klebsiella pneumoniae Infection in Solid Organ Transplant Recipients. Microbiology spectrum 11 (1) (2022)
Jingli Lu, Jiyun Liu, Lulu Li, Yan Lan, Yan Liang
Cytokines in type 1 diabetes: mechanisms of action and immunotherapeutic targets. Clinical & translational immunology 9 (3) (2020)
Jingli Lu, Lulu Li, Yan Lan, Yan Liang, Haiyang Meng
Immune checkpoint inhibitor-associated pituitary-adrenal dysfunction: A systematic review and meta-analysis. Cancer medicine 8 (18) (2019)
Jingli Lu, Lijuan Tang, Haiyang Meng, Junjie Zhao, Yan Liang
Effects of sodium-glucose cotransporter (SGLT) inhibitors in addition to insulin therapy on glucose control and safety outcomes in adults with type 1 diabetes: A meta-analysis of randomized controlled trials. Diabetes/metabolism research and reviews 35 (7) (2019)
Yongliang Yuan, Qitai Zhao, Songfeng Zhao, Penghua Zhang, Haibiao Zhao, Zeyun Li, Yue Du, Xin Tian, Jingli Lu
Characterization of transcriptome profile and clinical features of a novel immunotherapy target CD204 in diffuse glioma. Cancer medicine 8 (8) (2019)
Haiyang Meng, Ailing Zhang, Yan Liang, Jie Hao, Xiaojian Zhang, Jingli Lu
Effect of metformin on glycaemic control in patients with type 1 diabetes: A meta-analysis of randomized controlled trials. Diabetes/metabolism research and reviews 34 (4) (2018)